02.06.2013 Views

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

58 BACITRACIN<br />

(1997): Dyck ED+, Allergy 52(8), 870<br />

(1995): Knowles SR+, Int J Dermatol 34(8), 572<br />

(1994): Fox KA, JEmergNurs20(4), 262<br />

(1990): Eedy DJ+, Postgrad Med J 66(780), 858<br />

(1990): Sprung J+, Anesth Analg 71(4), 430<br />

(1987): Netl<strong>and</strong> PA+, Neurosurgery 21(6), 927<br />

(1986): Goh CL, Australas J Dermatol 27(3), 125<br />

(1984): Schechter JF+, Arch Dermatol 120(7), 909<br />

Injection-site pain<br />

Nephrotoxicity (from intramuscular injections)<br />

*Note: Bacitracin is supplied in many forms <strong>and</strong> vehicles:<br />

Intramuscular; topical, ophthalmic, otic, aerosols, for irrigations.<br />

Many Bacitracin ointments are combinations with Neomycin <strong>and</strong><br />

Polymyxin B.<br />

BACLOFEN<br />

Trade names: Alpha-Baclofen; Baclofen (Watson); Baclon;<br />

Baclosal; Baklofen; Clofen; Dom-Baclofen; Gen-Baclofen; Lebic;<br />

Lioresal (Medtronic); Nu-Baclo; Pacifen; PMS-Baclofen; Spinax<br />

Indications: Spasticity resulting from multiple sclerosis<br />

Category: GABA receptor agonist; Skeletal muscle relaxant<br />

Half-life: 2.5–4 hours<br />

Clinically important, potentially hazardous interactions<br />

with: alcohol<br />

Reactions<br />

Skin<br />

Allergic granulomatous angiitis<br />

(2006): Murphy PM+, Anesth Analg 102(3), 848<br />

Dermatitis<br />

Diaphoresis<br />

Exanthems<br />

(1983): Lynde CW+, Ann Neurol 13, 216<br />

Facial edema<br />

Peripheral edema<br />

(1993): Albright AL+, JAMA 270, 2475<br />

Pruritus<br />

(2005): Ben Smail D+, Arch Phys Med Rehabil 86(3), 494<br />

(withdrawal)<br />

Rash (sic) (1–10%)<br />

Side effects (sic) (1–2%)<br />

Toxicity (sic)<br />

(1994): Aisen ML+, Arch Phys Med Rehabil 75(1), 109<br />

Urticaria<br />

Mucosal<br />

Xerostomia (10%)<br />

Cyst (3–10%)<br />

Edema (generalized) (3–10%)<br />

Facial edema (3–10%)<br />

Genital edema (3–10%)<br />

Hematomas (3–10%)<br />

Herpes simplex (3–10%)<br />

Herpes zoster<br />

Peripheral edema (>10%)<br />

Pruritus (3–10%)<br />

(2002): Leonard PA+, Transplantation 74(12), 1697<br />

Rash (sic) (3–10%)<br />

(2002): Leonard PA+, Transplantation 74(12), 1697<br />

Ulcerations (3–10%)<br />

Vasculitis<br />

Wound complications (sic) (>10%)<br />

Mucosal<br />

Gingival hyperplasia/hypertrophy (3–10%)<br />

Stomatitis (3–10%)<br />

Tongue edema<br />

(2002): Leonard PA+, Transplantation 74(12), 1697<br />

Ulcerative stomatitis

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!